vs
Side-by-side financial comparison of FIRST HORIZON CORP (FHN) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $888.0M, roughly 1.7× FIRST HORIZON CORP). FIRST HORIZON CORP runs the higher net margin — 29.4% vs 4.4%, a 25.0% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 21.8%). FIRST HORIZON CORP produced more free cash flow last quarter ($389.0M vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 20.0%).
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
FHN vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $888.0M | $1.5B |
| Net Profit | $261.0M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 38.5% | 12.4% |
| Net Margin | 29.4% | 4.4% |
| Revenue YoY | 21.8% | 32.8% |
| Net Profit YoY | 57.2% | 143.8% |
| EPS (diluted) | $0.51 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $888.0M | $1.5B | ||
| Q3 25 | $889.0M | $1.4B | ||
| Q2 25 | $830.0M | $1.3B | ||
| Q1 25 | $812.0M | $1.1B | ||
| Q4 24 | $729.0M | $1.1B | ||
| Q3 24 | $827.0M | $1.0B | ||
| Q2 24 | — | $929.2M | ||
| Q1 24 | $819.0M | $751.7M |
| Q4 25 | $261.0M | $66.5M | ||
| Q3 25 | $262.0M | $124.8M | ||
| Q2 25 | $241.0M | $94.3M | ||
| Q1 25 | $218.0M | $1.3M | ||
| Q4 24 | $166.0M | $-151.9M | ||
| Q3 24 | $218.0M | $-121.3M | ||
| Q2 24 | — | $-120.4M | ||
| Q1 24 | $192.0M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 38.5% | 12.4% | ||
| Q3 25 | 38.7% | 11.5% | ||
| Q2 25 | 37.2% | 6.7% | ||
| Q1 25 | 35.1% | 1.0% | ||
| Q4 24 | 28.8% | -7.0% | ||
| Q3 24 | 34.0% | -12.0% | ||
| Q2 24 | — | -11.5% | ||
| Q1 24 | 31.0% | -34.8% |
| Q4 25 | 29.4% | 4.4% | ||
| Q3 25 | 29.5% | 8.8% | ||
| Q2 25 | 29.0% | 7.2% | ||
| Q1 25 | 26.8% | 0.1% | ||
| Q4 24 | 22.8% | -13.5% | ||
| Q3 24 | 26.4% | -12.1% | ||
| Q2 24 | — | -13.0% | ||
| Q1 24 | 23.4% | -33.4% |
| Q4 25 | $0.51 | $0.05 | ||
| Q3 25 | $0.50 | $0.08 | ||
| Q2 25 | $0.45 | $0.06 | ||
| Q1 25 | $0.41 | $0.00 | ||
| Q4 24 | $0.29 | $-0.10 | ||
| Q3 24 | $0.40 | $-0.09 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | $0.33 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $8.8B | $4.4B |
| Total Assets | $83.9B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $8.8B | $4.4B | ||
| Q3 25 | $8.9B | $4.1B | ||
| Q2 25 | $9.0B | $3.8B | ||
| Q1 25 | $8.7B | $3.5B | ||
| Q4 24 | $8.8B | $3.3B | ||
| Q3 24 | $9.0B | $3.4B | ||
| Q2 24 | — | $3.4B | ||
| Q1 24 | $8.9B | $3.4B |
| Q4 25 | $83.9B | $8.2B | ||
| Q3 25 | $83.2B | $7.6B | ||
| Q2 25 | $82.1B | $6.3B | ||
| Q1 25 | $81.5B | $5.8B | ||
| Q4 24 | $82.2B | $5.9B | ||
| Q3 24 | $82.6B | $5.8B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | $81.8B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $396.0M | $417.3M |
| Free Cash FlowOCF − Capex | $389.0M | $379.8M |
| FCF MarginFCF / Revenue | 43.8% | 25.4% |
| Capex IntensityCapex / Revenue | 0.8% | 2.5% |
| Cash ConversionOCF / Net Profit | 1.52× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $595.0M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $396.0M | $417.3M | ||
| Q3 25 | $-200.0M | $402.6M | ||
| Q2 25 | $83.0M | $263.6M | ||
| Q1 25 | $349.0M | $44.1M | ||
| Q4 24 | $191.0M | $75.2M | ||
| Q3 24 | $389.0M | $188.4M | ||
| Q2 24 | — | $-95.6M | ||
| Q1 24 | $838.0M | $-308.6M |
| Q4 25 | $389.0M | $379.8M | ||
| Q3 25 | $-208.0M | $354.5M | ||
| Q2 25 | $74.0M | $219.8M | ||
| Q1 25 | $340.0M | $-12.3M | ||
| Q4 24 | $174.0M | $-17.3M | ||
| Q3 24 | $383.0M | $54.7M | ||
| Q2 24 | — | $-205.5M | ||
| Q1 24 | $828.0M | $-465.1M |
| Q4 25 | 43.8% | 25.4% | ||
| Q3 25 | -23.4% | 25.1% | ||
| Q2 25 | 8.9% | 16.7% | ||
| Q1 25 | 41.9% | -1.1% | ||
| Q4 24 | 23.9% | -1.5% | ||
| Q3 24 | 46.3% | 5.5% | ||
| Q2 24 | — | -22.1% | ||
| Q1 24 | 101.1% | -61.9% |
| Q4 25 | 0.8% | 2.5% | ||
| Q3 25 | 0.9% | 3.4% | ||
| Q2 25 | 1.1% | 3.3% | ||
| Q1 25 | 1.1% | 5.0% | ||
| Q4 24 | 2.3% | 8.2% | ||
| Q3 24 | 0.7% | 13.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | 1.2% | 20.8% |
| Q4 25 | 1.52× | 6.28× | ||
| Q3 25 | -0.76× | 3.22× | ||
| Q2 25 | 0.34× | 2.79× | ||
| Q1 25 | 1.60× | 34.71× | ||
| Q4 24 | 1.15× | — | ||
| Q3 24 | 1.78× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 4.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FHN
| Commercial Consumer And Wealth Segment | $776.0M | 87% |
| Other | $88.0M | 10% |
| Corporate | $24.0M | 3% |
ONC
Segment breakdown not available.
